Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Buildings (2023 - 2024)

Historic Buildings for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Q4 2024 value amounting to $21.3 million.

  • Zhengye Biotechnology Holding's Buildings rose 100.25% to $21.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $21.3 million, marking a year-over-year increase of 100.25%. This contributed to the annual value of $21.0 million for FY2024, which is 244.23% down from last year.
  • Per Zhengye Biotechnology Holding's latest filing, its Buildings stood at $21.3 million for Q4 2024, which was up 100.25% from $21.1 million recorded in Q4 2023.
  • Zhengye Biotechnology Holding's 5-year Buildings high stood at $21.3 million for Q4 2024, and its period low was $21.1 million during Q4 2023.